In this supplement to EMJ Neurology, two leading experts in multiple sclerosis (MS), Prof Tjalf Ziemssen and Prof Diego Centonze, explored the sphingosine 1-phosphate (S1P) receptor modulators drug class and how they can be utilised in the management of patients with MS.
EMJ Neurology 8 [Supplement 2] . 2020
December 2020
In this issue
Latest articles
All articles![](https://www.emjreviews.com/wp-content/uploads/2024/05/Yaakov-Stern-Thumbnail-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/05/Jackie-French-Interview-Thumbnail-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/05/Movement-Disorder-Initial-Manifestation-of-Hereditary-Hemochromatosis-A-Case-Report-Thumbnail-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/05/NEU_Article_Tics-Temporally-Associated-with-940x564.png)